Thomas Watkins
Chief Executive Officer, HUMAN GENOME SCIENCES INC.
Companies
- Horizon Therapeutics Public Ltd CoBoard member Apr 17, 2014 to Oct 6, 20231
- Vanda Pharmaceuticals Inc.Board member Sep 12, 2006 to Jun 3, 20222
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Vanda Pharmaceuticals Inc. VNDA63,064 shares3$267.4K at $4.24Jun 2, 2022
- Horizon Therapeutics Public Ltd Co0 shares4Oct 6, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Oct 6, 2023Returned to company 10,000 shares at $116.50 of Horizon Therapeutics Public Ltd Co4
- Oct 6, 2023Returned to company 55,953 shares at $116.50 of Horizon Therapeutics Public Ltd Co4
- Oct 6, 2023Returned to company 110,447 shares at $116.50 of Horizon Therapeutics Public Ltd Co4
- Sep 29, 2023Exercised options 21,323 shares at $13.87 of Horizon Therapeutics Public Ltd Co5
- Sep 29, 2023Exercised options 20,000 shares at $15.96 of Horizon Therapeutics Public Ltd Co5
- Sep 29, 2023Exercised options 40,000 shares at $12.29 of Horizon Therapeutics Public Ltd Co5
- Apr 28, 2023Exercised options 3,913 shares of Horizon Therapeutics Public Ltd Co6
- Jun 2, 2022Sold 6,441 shares at $9.90 of Vanda Pharmaceuticals Inc.3
- Jun 2, 2022Exercised options 15,000 shares at $4.15 of Vanda Pharmaceuticals Inc.3
- Apr 29, 2022Exercised options 4,223 shares of Horizon Therapeutics Public Ltd Co7
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5SEC EDGARForm 4 filed Oct 2, 2023
- 6SEC EDGARForm 4 filed May 2, 2023
- 7SEC EDGARForm 4 filed May 2, 2022